期刊文献+

高血压病人血浆氧化低密度脂蛋白及细胞间黏附分子-1水平的变化 被引量:2

CHANGES OF PLASMA OXIDIZED LOW DENSITY LIPOPROTEIN AND SOLUBLE INTERCELLULAR ADHESION MOLECULE-1 IN PATIENTS WITH HYPERTENTION
下载PDF
导出
摘要 ①目的 探讨高血压病人血浆氧化低密度脂蛋白 (OX LDL)和可溶性细胞间黏附分子 1(sICAM 1)水平的变化及其意义。②方法 采用酶联免疫吸附法 (ELISA) ,检测了 10 8例高血压病人和 48例健康人血浆OX LDL、sICAM 1水平的变化。③结果 高血压病人血浆sICAM 1和OX LDL水平明显增高 ,与对照组比较差异有极显著性 (t=11.3 60、12 .85 1,P <0 .0 0 1) ,且Ⅰ、Ⅱ、Ⅲ期高血压病人OX LDL、sICAM 1比较差异亦有极显著意义 (F =19.75、2 2 .3 0 ,q =10 .62 5~ 14.3 3 1,P <0 .0 0 1) ,高血压病人OX LDL与sICAM 1含量呈正相关 (r=0 .668,P <0 .0 0 1)。④结论 高血压的发生与血浆sICAM 1和OX Objective To explore the changes of plasma oxidized low density lipoprotein (OX-LDL) and soluble intercellular adhesion molecule-1(sICAM-1). Methods By using the ELISA, the changes of OX-LDL and sICAM-1 levels were measured in 108 patients with hypertension and 48 healthy subjects. Results The OX-LDL and sICAM-1 levels were significantly higher in the patients than those in the controls (t=11.360, 12.851, P<0.001), and the increase of OX-LDL and sICAM-1 was more obvious along with the severity of patients' condition (F=19.75, 22.30, q=10.625-14.331, P<0.001). The OX-LDL was positively correlated with sICAM-1 in patients with hypertension (r=0.668, P<0.001). Conclusion The development of hypertension is closely related to the increase of OX-LDL and sICAM-1 levels.
出处 《齐鲁医学杂志》 2003年第1期9-10,共2页 Medical Journal of Qilu
关键词 高血压 脂蛋白类 LDL 细胞黏着分子 hypertension lipoproteins, LDL cell adhesion molecules
  • 相关文献

参考文献1

二级参考文献3

共引文献3

同被引文献22

  • 1吕学祥,梁国芬.氧化型低密度脂蛋白和血脂康对人脐静脉内皮细胞产生一氧化氮合酶和细胞间黏附分子-1的影响[J].临床心血管病杂志,2004,20(6):355-357. 被引量:9
  • 2Sattar N, Bendomir A, Berry C, et al. Lipoprotein subfraction concentrations in preeclampsia: pathogenic parallels to atherosclerosis. Obstet Gynecol, 1997, 89:403-408.
  • 3Gearing AJ, Newman W. Circulating adhesion molecules in disease. Immunol Today, 1993,14:506-512.
  • 4Khan BV, Parthasarathy SS, Alexander RW, et al. Modified low density lipoprotein and its constituents augment cytokineactivated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells. J Clin Invest, 1995, 95:1262-1270.
  • 5Calara F, Dimayuga P, Niemann A, et al. An animal model to study local oxidation of LDL and its biological effects in the arterial wall. Arterioscler Thromb Vasc Biol, 1998, 18: 884-893.
  • 6Bombardier C’Gladman DD,Urowitz MB,et al .Derivation of the SLEDAI.A disease activity index for lupus patients.The Committee on PrognosisStudies in SLE[J], Arthritis Rheum, 1 992,35(6): 630-640.
  • 7Zhou TB,Liu YG,Lin N,et al .Relationship between angiotensin-convertingenzyme insertion/deletion gene polymorphism and systemic lupuserythematosus/lupus nephritis.a systematic review and metaanalysisfJ].JRheumatol ,201 2, 39. 686-693.
  • 8Hill GS, Delahousse M’Nochy D,et a 1 . Proteinuria and tubulointerstitiallesions in lupus nephritis[J],Kidney Int,2001 ,60(5): 1 893-1903.
  • 9Jacobsen s.Starklint H, Petersen J ,et a 1 . Prognostic value of renalbiopsy and clinical variables in patients with lupus nephritis[J].Scand JRheumatol ,1999,28.288-299.
  • 10游运辉,左晓霞,尹红玲,罗卉,赵洪军,刘萍.71例狼疮性肾炎的病理与临床分析[J].中国现代医学杂志,2008,18(5):626-627. 被引量:8

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部